Aim: N-3 fatty acids, especially eicosapentaenoic acid (EPA), may possess anticachectic properties. This trial compared a protein and energy dense supplement enriched with n-3 fatty acids and antioxidants ( experimental: E) with an isocaloric isonitrogenous control supplement ( C) for their effects on weight, lean body mass ( LBM), dietary intake, and quality of life in cachectic patients with advanced pancreatic cancer
OBJECTIVE: Cachexia is a nutrient deficient condition affecting millions of cancer patients. Cancers...
A transplantable murine colon adenocarcinoma (MAC16) was utilised as a model of human cancer cachexi...
Recent studies show that ω-3 polyunsaturated fatty acids (PUFAs) have the capacity to modulate ...
Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and l...
Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and l...
Journal Article; Research Support, Non-U.S. Gov't; Review;Use of n-3 fatty acids (FA) has been repor...
PubMedID: 19090549Background. The aim of nutritional therapy in cancer patients is to prevent weight...
Cancer cachexia is a syndrome characterized by high prevalence and multifactorial etiology. The path...
Background- Cancer cachexia is a distressing weight loss syndrome commonly seen in advanced cancer p...
In cancers where high inflammatory stress is usual, protein rich supplements containing n-3 polyunsa...
The acute-phase protein response is associated with accelerated weight loss and shortened survival i...
Background & aims: Recent reports suggest that weight loss in cachectic cancer patients may be i...
The impact of the Western diet on chronic diseases, such as cancer, has been well recognized. Dietar...
The project identified changes in molecular markers of antioxidant status and muscle atrophy during ...
Cachexia is a frequent problem in cancer patients associated with mortality and morbidity since it c...
OBJECTIVE: Cachexia is a nutrient deficient condition affecting millions of cancer patients. Cancers...
A transplantable murine colon adenocarcinoma (MAC16) was utilised as a model of human cancer cachexi...
Recent studies show that ω-3 polyunsaturated fatty acids (PUFAs) have the capacity to modulate ...
Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and l...
Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and l...
Journal Article; Research Support, Non-U.S. Gov't; Review;Use of n-3 fatty acids (FA) has been repor...
PubMedID: 19090549Background. The aim of nutritional therapy in cancer patients is to prevent weight...
Cancer cachexia is a syndrome characterized by high prevalence and multifactorial etiology. The path...
Background- Cancer cachexia is a distressing weight loss syndrome commonly seen in advanced cancer p...
In cancers where high inflammatory stress is usual, protein rich supplements containing n-3 polyunsa...
The acute-phase protein response is associated with accelerated weight loss and shortened survival i...
Background & aims: Recent reports suggest that weight loss in cachectic cancer patients may be i...
The impact of the Western diet on chronic diseases, such as cancer, has been well recognized. Dietar...
The project identified changes in molecular markers of antioxidant status and muscle atrophy during ...
Cachexia is a frequent problem in cancer patients associated with mortality and morbidity since it c...
OBJECTIVE: Cachexia is a nutrient deficient condition affecting millions of cancer patients. Cancers...
A transplantable murine colon adenocarcinoma (MAC16) was utilised as a model of human cancer cachexi...
Recent studies show that ω-3 polyunsaturated fatty acids (PUFAs) have the capacity to modulate ...